PET及PET-CT在放射治疗计划中的应用价值

刘滔 严惟力 黄钢

引用本文:
Citation:

PET及PET-CT在放射治疗计划中的应用价值

  • 基金项目:

    上海市教委重点发展基金项目(04BA03)

    上海市科委重点基金项目(04JC14044)

  • 中图分类号: R814.42;R817.4

The role of PET and PET-CT in the radiotherapy plan

  • CLC number: R814.42;R817.4

  • 摘要: 肿瘤放射治疗已进入PET及PET-CT引导的生物适形治疗时代,PET及PET-CT改进和优化了综合治疗计划的实施,改进了放疗计划的实施目的,精确了肿瘤放疗靶区的制定,同时在靶区勾画过程中大大减少了不同医生所勾画靶区的差异,并减少了勾画靶区的偏倚,通过准确靶区范围而使治疗-效益比提高.
  • [1] Heron DE, Simth RP, Andrade RS. Advancers in image-guided radiation therapy-the role of PET-CT. Med Dosim, 2006, 31(1):3-11.
    [2] Van TinterenH, Hoekstra, OS, Smit EF, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer:the PLUS multicentre randomized trial. Lancet, 2002, 359(9315):1388-1393.
    [3] Van Westreenen HL, Heeren PA, Van DHM, et al. Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents nnnecessary surgical exploraions. J. Gastrointest. Surg, 2005, 9(1):54-61.
    [4] Radan L, Ben-Haim S, Bar-Shalom R, et al. The role of FDG-PETCT in suspected reeurrence of breast cancer. Cancer, 2006, 107(11):2545-2551.
    [5] Huebner RH, Park KC, Shepherd JE, et al. A meta-analysis of the literature for whole-body FDG PET deteetion of reeurrent colorectal cancer. J Nucl Ned, 2000, 41(7):1177-1189.
    [6] Dizendorf EV, Baumert BC, Von Sehulthess GK, et al. Impact of whole-body 18F-FDG PET on staging and managing patients for radiation therapy. J Nucl Med, 2003, 44(1):24-29.
    [7] Ciernik IF, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET-CT):a feasibility study. Int J Radiat Orxcol Biol Phys, 2003, 57(3):853-863.
    [8] Mourean-Zabotto L, Touboul E, Lerouge D, et al. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma. Int J Radiat Oncol Biol Phys, 2005, 63(2):340-345.
    [9] Zheng XK, Chen LH, Wang QS, et al. Influence of[18F] fluorodeoxyglueose positron emission tomography on salvage trealment decision making for locally persistent nasopharyneal carcinoma. Int J Radiat Oncnl Biol Phys, 2006, 65(4):1020-1025.
    [10] Deniaud-Alexandre E, Touboal E, Lerouge D, et al. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer. IntJ Radiat Oncol Biol Phys, 2005, 63(5):1432-1441.
    [11] Leong T, Everitt C, Yuen K, et al. A prospective study to evaluale the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. Radiother Oncol, 2006, 78(3):254-261.
    [12] Steenbakkers R J, Duppen JC, Fitton I, et al. Reduction of observer variation using matched CT-PET for lung cancer delineation:A three-dimensinnal analysis. Int J Radiat Oneol Biol Phys, 2006, 64(2):435-448.
    [13] Paulino AC, Koshy M, Howell R, et al. Comparison of CT-and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys, 2005, 61(5):1385-1392.
    [14] VespriniD, UngY, Kamra J, et al.The Addition of 18-fluorodeoxyglueose positron emission tomography (FDG-PET) to CT based radiotherapy planning of carcinoma of the esophagus decreases both the intra and interobserver variability of GTV delineation. Int J Radiat Oncol Biol Phys, 2006, 66(3,suppl):S299-S300.
    [15] Riegel AC, Berson AM, Destian S, et al. Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET-CT fusion. Inl J Radial Oncol Biol Phys, 2006, 65(3):726-732.
    [16] Bradley J, Thorstad WL, Mutic S, et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 2004, 59(1):78-86.
    [17] Grosu AL, Weber WA, Astner ST, et al. 11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys, 2006, 66(2):339-344.
  • [1] 朱苏雨胡炳强 . PET-CT用于肿瘤精确放疗靶区勾画的困惑. 国际放射医学核医学杂志, 2007, 31(4): 217-221.
    [2] 黄劲雄吴华 . 功能性影像在脑胶质瘤放射治疗靶区确定中的应用. 国际放射医学核医学杂志, 2007, 31(2): 108-112.
    [3] 乔文礼赵晋华18F-氟脱氧葡萄糖PET在靶区确定和放疗计划制定中的价值. 国际放射医学核医学杂志, 2007, 31(6): 345-349.
    [4] 郭慧敏赵晋华 . 应用影像学方法评价乳腺癌新辅助化疗疗效. 国际放射医学核医学杂志, 2009, 33(3): 149-153. doi: 10.3760/cma.j.issn.1673-4114.2009.03.006
    [5] 夏伟罗全勇袁志斌 . PET-CT在肿瘤放射治疗中的应用. 国际放射医学核医学杂志, 2006, 30(6): 331-335.
    [6] 陈香赵晋华 . PET及PET-CT在监测肿瘤治疗效果中的价值. 国际放射医学核医学杂志, 2007, 31(6): 354-358.
    [7] 隗功华孙晓光 . 医学影像学在肿瘤治疗疗效评价中的应用. 国际放射医学核医学杂志, 2009, 33(1): 43-46. doi: 10.3760/cma.j.issn.1673-4114.2009.01.043
    [8] 赵惠扬 . 放射性核素计算机处理断层摄影术. 国际放射医学核医学杂志, 1979, 3(1): 36-41.
    [9] 叶慧莫逸谢爱民彭翔18F-氟脱氧葡萄糖PET-CT与99nTc-亚甲基二膦酸盐骨显像诊断转移性骨肿瘤的对比研究. 国际放射医学核医学杂志, 2008, 32(3): 147-150.
    [10] 张悦18F-氟脱氧葡萄糖PET和PET-CT在结直肠癌术后复发或转移中的应用价值. 国际放射医学核医学杂志, 2007, 31(1): 34-36.
    [11] 杨吉刚李春林18F-氟脱氧葡萄糖PET及PET-CT在食管癌中的. 国际放射医学核医学杂志, 2007, 31(1): 31-33.
  • 加载中
计量
  • 文章访问数:  1581
  • HTML全文浏览量:  82
  • PDF下载量:  6
出版历程
  • 收稿日期:  2007-03-21

PET及PET-CT在放射治疗计划中的应用价值

  • 1. 200127 上海, 上海交通大学医学院附属仁济医院核医学科;
  • 2. 200127 上海, 上海交通大学医学院临床核医学研究所
基金项目:  上海市教委重点发展基金项目(04BA03)上海市科委重点基金项目(04JC14044)

摘要: 肿瘤放射治疗已进入PET及PET-CT引导的生物适形治疗时代,PET及PET-CT改进和优化了综合治疗计划的实施,改进了放疗计划的实施目的,精确了肿瘤放疗靶区的制定,同时在靶区勾画过程中大大减少了不同医生所勾画靶区的差异,并减少了勾画靶区的偏倚,通过准确靶区范围而使治疗-效益比提高.

English Abstract

参考文献 (17)

目录

    /

    返回文章
    返回